Christopher Verni - 19 Apr 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
General Counsel
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
19 Apr 2022
Transactions value $
$0
Form type
4
Date filed
20 Apr 2022, 18:06
Next filing
04 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +150K $0.00 150K 19 Apr 2022 Common Stock 150K $7.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on April 19, 2023 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter.